Kymera Therapeutics is Named one of the FierceBiotech's Fierce 15 Companies of 2019
Descrição
/PRNewswire/ -- Kymera Therapeutics Inc., a biotechnology company advancing the field of targeted protein degradation to create next generation medicines
FierceBiotech's 2019 Fierce 15
Kymera Therapeutics: A Status Update (NASDAQ:KYMR)
tak-20220331
Faber Daeufer & Itrato Faber Representation is Once Again Prevalent…
Fierce Biotech's 2021 Fierce 15
Outlook 2023 - Biotech 360°: A slow starter blasting off into a
News Sanofi Ventures
Carmine Therapeutics named as one of FierceBiotech's Fierce 15
FierceBiotech's 2019 Fierce 15
de
por adulto (o preço varia de acordo com o tamanho do grupo)